J&J pulls more children's drugs off store shelves

Johnson & Johnson ($JNJ) execs should write a blues song about recalls.

Johnson & Johnson ($JNJ) execs should write a blues song about recalls. The company has found more manufacturing problems at its now-closed-for-remodeling plant in Fort Washington, PA, so it's pulling about 4 million packages of children's Benadryl tablets and 800,000 bottles of junior Motrin caplets off store shelves and out of wholesale warehouses.

Packages of drugs that are already in consumers' hands aren't affected, however. The company says the products are safe for continued use, because they passed quality testing and haven't prompted any complaints about side effects.

Earlier this year, J&J's McNeil Consumer Healthcare unit recalled 34 million bottles of children's drugs made at the Fort Washington plant, and the FDA released a scathing inspection report about the facility's condition and procedures. The plant was shut down--and most of its work force laid off--so that it could be retooled to fix the problems. J&J said the latest recall stems